Endovascular repair of aortic disease: A venture capital perspective

Seminars in Interventional Radiology

Volumn 26, Issue 1, 2009, Pages 56-66

  Buchanan, Lucas W ^a   Stavropoulos, S William ^b   Resnick, Joshua B ^c   Solomon, Jeffrey ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Aneurysms; Aortic disease; Endografts; Endovascular therapy; Venture capital

Indexed keywords

EID: 63149130206     PISSN: 07399529     EISSN: 10988963     Source Type: Journal    
DOI: 10.1055/s-0029-1208384     Document Type: Review

References (30)

1. Platzer M. Patient Capital. National Venture Capital Association. Available at: http://nvca.org/pdf/NVCAPatientCapital.pdf. Accessed December 30, 2008
2. Ackerly DC, Valverde AM, Diener LW, et al. Fueling innovation in medical devices (and beyond): venture capital in health care. Health Aff (Millwood) 2009;28:w68-w75
3. National Venture Capital Association. Available at: http://www.nvca.org/ pdf/q208VCPerformanceRelease.pdf. Accessed December 31, 2008
4. Yearbook 2008 National Venture Capital Association. Available at: http://nvca.org/pdf/NVCAYearbook2008.pdf. Accessed December 18, 2008
5. Ferrari R. Value Creation for Health Care Startups. In: Health Care Venture Capital Best Practices. Boston, MA: Aspatore; 2008
6. VenturXpert database. Available at: http://vx.thomsonib.com/NASApp/ VxComponent/VXMain.jsp. Accessed December 29, 2008
7. U.S. Venture Partners. Investment approach page. Available at: http://www.usvp.com/html-vers/approach.html. Accessed January 5, 2009
8. Saftlas H. Industry Surveys - Healthcare: Pharmaceuticals. New York, NY: Standard & Poors; 2008
9. Stewart K, Hu C, Cal L. Medtech Analyzer: October 2008: Buckle Up, Things May Get Bumpy. Credit Suisse; 2008
10. Medtronic 2008 10K SEC filing. Available at: http://investorrelations. medtronic.com/secfiling.cfm?filingID=897101-08-1392. Accessed January 5, 2009
11. Lee T, Yee C. Medtronic, Inc: Premier Franchise in Medical Technology. San Francisco, CA: Piper Jaffray; 2008
12. U.S. Market for Peripheral Vascular Devices. Vancouver, Canada: iData Research Inc.; 2007
13. U.S. Markets for Peripheral Vascular Devices. Toronto, Canada: Millenium Research Group; 2007
14. Leurs LJ, Buth J, Laheij RJ. Long-term results of endovascular abdominal aortic aneurysm treatment with the first generation of commercially available stent grafts. Arch Surg 2007;142:33-41
15. van Marrewijk CJ, Leurs LJ, Vallabhaneni SR, et al. Risk-adjusted outcome analysis of endovascular abdominal aortic aneurysm repair in a large population: how do stent-grafts compare? J Endovasc Ther 2005;12:417-429
16. EVAR Trial Participants. Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Lancet 2005;365:2179-2186
17. Prinssen M, Verhoeven EL, Buth J, et al. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med 2004;351:1607-1618
18. Moise MA, Woo EY, Velazquez OC, et al. Barriers to endovascular aortic aneurysm repair: past experience and implications for future device development. Vasc Endovascular Surg 2006;40:197-203
19. Makaroun MS, Dillavou ED, Kee ST, et al. Endovascular treatment of thoracic aortic aneurysms: results of the phase II multicenter trial of the GORE TAG thoracic endoprosthesis. J Vasc Surg 2005;41:1-9
20. Ricotta JJ, Oderich GS. Fenestrated and branched stent grafts. Perspect Vasc Surg Endovasc Ther 2008;20:174-187; discussion 188-189
21. Donas KP, Kafetzakis A, Umscheid T, et al. Vascular endostapling: new concept for endovascular fixation of aortic stent-grafts. J Endovasc Ther 2008;15:499-503
22. Rosen RJ, Green RM. Endoleak management following endovascular aneurysm repair. J Vasc Interv Radiol 2008;19(suppl):S37-S43
23. Prinssen M, Verhoeven EL, Buth J, et al. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med 2004;351:1607-1618
24. Burns LR, Housman MG, Robinson CA. Market entry and exit by biotech and device companies funded by venture capital. Health Aff (Millwood) 2009;28:w76-w86
25. Motley Rice. Guidant Ancure Endograft System page. Available at: http://motleyrice.com/medical/devices/GuidantAncureEndograftSystem/default.asp. Accessed December 30, 2008
26. Wallack T. Boston Scientific cited by FDA for procedures. The Boston Globe; 2007. Available at: http://www.boston.com/business/healthcare/articles/ 2007/09/08/boston-scientific-cited-by-fda-for-procedures/. Accessed December 29, 2008
27. Boston Scientific 2006 10K SEC filing. Available at: http://www.secinfo. com/d1znFa.uhw.htm. Accessed January 5, 2009
28. Katzen BT, MacLean AA. Past, present, and future endograft devices. Tech Vasc Interv Radiol 2005;8:16-21
29. Edwards Lifesciences. Newsroom page. Available at: http://www.edwards. com/newsroom/nr20040406.htm. Accessed December 30, 2008
30. Parodi FE, Mao D, Ennis TL, et al. Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-kappaB. J Vasc Surg 2005;41:479-489